MedTech Acquisition Corpo...

NASDAQ: MTAC · Real-Time Price · USD
11.34
1.78 (18.67%)
At close: Aug 10, 2023, 10:00 PM

MedTech Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
29.43M n/a n/a
Cost of Revenue
4.1M n/a n/a
Gross Profit
25.33M n/a n/a
Operating Income
-36.16M -2.75M -3.04M
Interest Income
404K 3.02M 64K
Pretax Income
-30.04M 6.11M 4.77M
Net Income
-33.23M 5.54M 4.77M
Selling & General & Admin
43.8M 2.75M 3.04M
Research & Development
17.69M n/a n/a
Other Expenses
n/a n/a n/a
Operating Expenses
61.49M 2.75M 3.04M
Interest Expense
-3.09M n/a n/a
Selling & Marketing Expenses
25.84M n/a n/a
Cost & Expenses
65.6M 2.75M 3.04M
Income Tax Expense
-6K 570.85K n/a
Shares Outstanding (Basic)
n/a 31.25M 31.25M
Shares Outstanding (Diluted)
n/a 31.25M 31.25M
EPS (Basic)
n/a 0.18 0.15
EPS (Diluted)
n/a 0.18 0.15
EBITDA
-36.16M -8.58M -10.78M
EBIT
n/a -2.75M -3.04M
Depreciation & Amortization
n/a -5.84M -7.74M